What a year 2024 has been! We celebrated our 10^th anniversary with the MedTech Forum where we had over 2,000 attendees, 100 international speakers including Nobel-Prize-winner Malala Yousafzai and healthcare AI experts like Tom Lawry and Dr Brent James.

We wanted to take this opportunity to unequivocally and sincerely thank our board and committee members for their tireless work and support to enhance healthcare outcomes and access across APAC.

Advocacy wins include Singapore’s exemptions for Dechlorane Plus and UV-328 and getting invited by governments of Malaysia (Medical Device Authority), Indonesia (MOH) and China (NMPA) to shape policies on change management, electronic IFU guideline revisions, and regulatory reliance respectively.

We also reached over 1000 policymakers across the region via capacity building trainings, covering topics not limited to data interoperability standards and SaMD regulations, and launched APACMed’s position on key issues such as ethical considerations for applying AI in MedTech in APAC.

Further, we convened authorities from Japan, Korea, Australia and Singapore together for digital health reimbursement dialogues. We also launched the APACMed Innovation Community (AIC) for start-ups to be connected to the healthcare ecosystem – more to come in 2025, so watch this space!

We wrapped up this year by clinching the BioSpectrum Awards for “Outstanding Leadership in MedTech Advocacy in APAC”! (insert link to website)

Some key resources we have made available to you are our E-learning hub, Integrated Resources Page, Regulatory Intelligence Bulletin, and the Environmental Policy Dashboard 2.0.

Your continued interest and involvement in 2025 are coveted by all of us at the APACMed Secretariat. We’ve extracted our key achievements this year below, for your ease of reference. For a fuller low-down, please watch this space for our Annual Report in March 2025.